Skip to Content

b 35 719 (Alendronate Sodium 35 mg)

Pill with imprint b 35 719 is White, Elliptical / Oval and has been identified as Alendronate Sodium 35 mg. It is supplied by Barr Laboratories, Inc..

Alendronate is used in the treatment of osteoporosis; prevention of osteoporosis; paget's disease and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Alendronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for b 35 719

Alendronate sodium 35 mg b 35 719

Alendronate Sodium

Imprint
b 35 719
Strength
35 mg
Color
White
Size
10.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Barr Laboratories, Inc.
National Drug Code (NDC)
00555-0719

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.